Last5.69 +0.06 (+1.07%)
4.951 - 10.09
52 Week Range
Technical Indicators (Daily)
Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced today tha...
We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are also......
Viking Therapeutics Announces Initiation of Phase 1b Clinical Trial of VK0214 in Patients with X-ALD
Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the i...
What happened Shares of the developmental-stage biotech Viking Therapeutics (NASDAQ: VKTX) jumped by as much as 11.2% in pre-market action Thursday morning. The company's shares perked up in response ...
Viking Therapeutics Inc (NASDAQ: VKTX) has announced results from its Phase 1 trial of VK0214 in healthy volunteers. VK0214 demonstrated encouraging safety and tolerability at all doses, as well as a ...
Disclaimer: The data contained in Super Surge website is not necessarily real-time nor accurate and may differ from the actual market data. Prices, volumes, ratios, charts and indicators are indicative and not appropriate for trading purposes. Super Surge doesn't bear any responsibility for any trading losses you might incur as a result of using this data.